Daniel sells ELGX 13.97: Endologix Reports 13% Global Revenue Growth For The Second Quarter 2014
IRVINE, Calif., July 30, 2014 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, today announced financial results for the three and six months ended June 30, 2014. John McDermott ... ...
49 people liked this
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home